Page results
-
The UCLH immunotherapy-neurotoxicity multidisciplinary service (IO-neurotox MDT) was established collaboratively between the National Hospital for Neurology and Neurosurgery (NHNN) and a nationwide oncology clinical team to offer high-quality diagnostic and management guidance on the care of cancer patients with, or suspected of having, any form of neurological complication of immunotherapy (immune-checkpoint inhibitor therapy).
-
This service is unique in the UK, offering an adolescent rheumatology service that provides diagnostic and therapeutic advice to patients with any rheumatic diseases that occur in adolescence.
-
Patient information who have been recommended to use a Biatain® dressing on your skin that has broken down due to your radiotherapy or proton beam therapy treatment.
-
Patient information for patients who have been recommended to use a Mepilex® dressing on their skin that has broken down due to your radiotherapy or proton beam therapy treatment.
-
Patient information for patients who have been recommended to use a Polymem® dressing on your skin that has broken down due to radiotherapy or proton beam therapy treatment.
-
Information about the autogenic training service at the Royal London Hospital for Integrated Medicine.
-
Information on robotic hysterectomy with or without bilateral salpingo-oophorectomy (removal of tubes and ovaries).
-
This page provides information about the thermoregulatory sweat test (TST).
-
This booklet has been written by the Autonomic Unit at The National Hospital for Neurology and Neurosurgery (NHNN). The aim of the booklet is to provide information about the Dynamic Sweat Test (DST).
-
This page is for patients who have been asked to take part in a service evaluation looking at Magnetic Resonance Imaging (MRI) at the Proton Beam Therapy department at UCLH. This information explains why we are doing this evaluation and what it would involve for you.
File results
-
FOI/2022/0391 - Research into Covid-19 loss of smell and taste
-
FOI/2022/0405 - Treatments C1-esterase inhibitor & immunoglobulin treatments
-
FOI/2022/0407 - Rooftop and greenfield mobile mast site agreements
-
FOI/2022/0411 - Resident Medical Officers/ Resident Doctors/ Senior House Officers supplied by agencies
-
FOI/2022/0421 - Paediatric autoimmune neuropsychiatric disorders
-
FOI/2022/0422 - Annual salary directors
-
FOI/2022/0443 - Trust spend on lost, stolen or damaged patient property
-
FOI/2022/0465 - Treatment of dermatological conditions
-
FOI/2022/0470 - Total spend on agency staff
-
FOI/2022/0485 - ACR laboratory device